Navigation Links
China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results
Date:4/15/2009

," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the progress of new product development. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.



                 CHINA SKY ONE MEDICAL, INC. AND SUBSIDIARIES
                    CONSOLIDATED STATEMENTS OF OPERATIONS
   FOR THE THREE MONTHS AND TWELVE MONTHS ENDED DECEMBER 31, 2008 AND 2007

                               Three Months Ended          Years Ended
                                  December 31,             December 31,
                                  2008        2007        2008        2007
                                  (Unaudited)              (Audited)

    Revenues                $25,954,879 $12,723,375 $91,816,183 $49,318,308
    Cost of Goods Sold        6,654,502   2,835,176  22,403,303  10,939,531
    Gross Profit             19,300,377   9,888,199  69,412,880  38,378,777

    Operating Expenses
          Selling, general
           and administrative 7,341,394   3,365,194  25,482,201  16,163,577
          Depreciation and
           amortization         335,031     166,556     858,406     443,063
          Research and
           development        2,693,341   1,406,
'/>"/>
SOURCE China Sky One Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...wswire-FirstCall/--deCODE,genetics,Inc.(Nasdaq: DC...asdaqStockMarketthattradinginthecompany,scommonsto...Ewillbefiledwiththe,SecuritiesandExchangeCommissio...Nasdaq,unlessthecompanyfilesanappealtotheNasdaq,Li...ppeal,which,willstaythesuspensionanddelistingthrou...
(Date:11/24/2009)...wswire-FirstCall/--deCODE,genetics,Inc.(Nasdaq: DC...motionsbytheU.S.BankruptcyCourtfortheDistrictofDel...oluntarypetitionfor,reliefunderChapter11oftheUnite..., TheordersissuedbytheBankruptcyCourtallowthecomp...11proceedings.Inparticular,the,companyreceivedinte...
(Date:11/24/2009)...-ShanghaiBiolaxyannouncedthe,ChineseStateFood&...onalnewdrugapplication(IND)foritsoralinsulinprojec...abetes.ThisIND,approvalallowsBiolaxytoinitiateitsf...rcharacteristicofhighbloodglucoseandpoor,metabolis...ro-and,macro-vasculardiseases,lossofvision,kidneyf...
(Date:11/24/2009)...forpatientswithadvanced-stage,orrecurrentendometri...tCall/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(...edonendocrinetherapyandoncology,todayannouncedposi...otoxicpeptideconjugate,AEZS-108(formerlyAN-152),in...napersonalizedhealthcareapproach,thestudyselectedp...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics"...ata from three clinical trials using REOLYSIN are ...iety of Clinical Oncology (ASCO) Annual Meeting. T... 29-June 2, 2009. The abstracts are available on t... REOLYSIN poster presentations, - Dr. Monica ...
...Calif., May 14 Bayer HealthCare Pharmaceuticals, ...X ) today announced that more than 65 studies eval...ill be presented at the 2009 American Society of C...var has a proven track record in two cancers - in ...noma (HCC), or liver cancer, and in the treatment ...
...T NOW(R), the first retail direct-access lab testi...s partnered with Atherotech, Inc., a Birmingham, A... Cholesterol Test direct to consumers at an afford...d cholesterol profile that identifies a greater nu...l test to directly measure LDL. , , ANY LAB TEST...
Other Biology Technology:Oncolytics Biotech(R) Inc.'s Research Collaborators to Present Data on REOLYSIN(R) Clinical Trials at ASCO Conference 2Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 2Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 3Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 4Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 5Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 6VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R) 2VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R) 3
(Date:11/25/2009)...sy lives. In addition to mammalian immune systems ...alled bacteriophages, viruses that kill half the b...ria and another class of microorganisms called arc...h as deep-sea volcanic vents) manage just fine, th...nse system that helps protect them from many virus...
(Date:11/25/2009)... professors recently received funding from the Nat...h beneficial to understanding the environment. The...kwood, assistant professor in the Department of Bi...wo separate research projects. , His first proje...es and Functions from the Leaf to the Landscape," ...
(Date:11/24/2009)...ein that may help gut bacteria bind to the gastroi...iotic producers to identify strains that are likel...need to interact with cells lining the gut to have...es in the gut they are more likely to stick around...halie Juge from the Institute of Food Research. I...
Breaking Biology News(10 mins):Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Kent State University professors focus research on the environment with grants totaling $890,000 2A sticky solution for identifying effective probiotics 2When palm trees gave way to spruce trees 8890 1When palm trees gave way to spruce trees 8890 2St Gallen consensus 2009 3A A radically different approach to treating early breast cancer 49311 1St Gallen consensus 2009 3A A radically different approach to treating early breast cancer 49311 2St Gallen consensus 2009 3A A radically different approach to treating early breast cancer 49311 3National Changing Diabetes Program Issues Statement on President Obamas Speech to the American Medical Association 49308 1
...sions with a sticky protein on the tip that lets t...e structure of the protrusions helps the bacteria ...e the body, researchers report in the journal PLoS...ity of Washington in Seattle and ETH Zurich in Swi...oli attaches to mucous membranes in the body. In t...
...age to exist and even thrive in surroundings rangi...of scientists from the Weizmann Institute,s Plant ...has found that a switch in just two amino acids (t...ce between functioning best at moderate temperatur...e results of their research, which recently appear...
...ect Antarctica ?the world,s last great wilderness ... at a meeting of Antarctic experts in Edinburgh. ,...aty Consultative Meeting, which finished at Edinbu...une, agreed new measures that will reduce the risk...marine and terrestrial ecosystems in Antarctica. ,...
Other Biology News:Tiny shock absorbers help bacteria stick around inside the body 2Bacteria beat the heat 2Antarctic Treaty Meeting moves to protect frozen continent from non-native species 2
Pig Trypsin from BIOPUR
Rabbit Anti-Human PALLD Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Cloning and Expression Services from Molecular Biology Resources
Cat IgA ELISA Kit from Bethyl Laboratories
Biology Products: